Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Tax Provisions (2019 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Tax Provisions for 7 consecutive years, with $257000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 314.52% to $257000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $487000.0, a 34.45% decrease, with the full-year FY2024 number at $166000.0, up 109.78% from a year prior.
  • Tax Provisions was $257000.0 for Q3 2025 at Xtant Medical Holdings, up from $255000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $577000.0 in Q4 2023 to a low of -$2.3 million in Q3 2023.
  • A 5-year average of -$51705.9 and a median of $23000.0 in 2021 define the central range for Tax Provisions.
  • Biggest YoY gain for Tax Provisions was 2647.62% in 2023; the steepest drop was 17792.31% in 2023.
  • Xtant Medical Holdings' Tax Provisions stood at $30000.0 in 2021, then fell by 30.0% to $21000.0 in 2022, then surged by 2647.62% to $577000.0 in 2023, then crashed by 89.25% to $62000.0 in 2024, then soared by 314.52% to $257000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Tax Provisions are $257000.0 (Q3 2025), $255000.0 (Q2 2025), and -$25000.0 (Q1 2025).